权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Use of insulin sensitizers to offset skeletal muscle dysfunction during immobility

使用胰岛素增敏剂来抵消不动期间的骨骼肌功能障碍

基本信息

批准号：
9805099
负责人：
Micah J Drummond
金额：
$ 22.88万
依托单位：
UNIVERSITY OF UTAH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-01 至 2022-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9805099
关键词：
Acute Adult Age Anabolism Attenuated Bed Occupancy Bed rest Ceramides Characteristics Clinical Research Data Development Disease Distress Dose Elderly Enzymes Event Foundations Functional disorder Genetic Transcription Goals Grant Growth Health Hindlimb Suspension Hospitalization Immobilization Impairment Inflammation Inflammatory Injury Insulin Intervention Leg Link Lipids Metformin Mus Muscle Muscle Cells Muscle Fibers Muscle Weakness Muscle function Muscular Atrophy Non-Insulin-Dependent Diabetes Mellitus Operative Surgical Procedures Oral Pathway interactions Patients Pharmaceutical Preparations Pharmacology Physical Function Physical activity Placebos Population Prevention strategy Preventive therapy Randomized Recovery Risk Rodent Signal Transduction Skeletal Muscle Testing Thigh structure Time Tissues Up-Regulation anti aging attenuation base cell growth cost effective cytokine gastrointestinal improved insulin sensitivity insulin sensitizing drugs muscle form muscle strength novel novel therapeutic intervention physical inactivity physical model preservation prevent sarcopenia sedentary lifestyle side effect skeletal muscle wasting

项目摘要

Abstract Hospitalizations for disease, injury, and/or surgery in older adults are likely to impair physical mobility and, therefore, the older adults capacity to be physically active both during hospitalization and beyond. The resulting sedentary lifestyle is likely to be accepted as the new normal, ultimately increasing the risk of skeletal muscle dysfunction (e.g. sarcopenia). Muscle atrophy and loss in strength is an unfortunate consequence with disuse in older adults. We have observed with our bed rest studies in healthy older adults that in addition to muscle and strength changes, there is a substantial increase in skeletal muscle inflammation and an upregulation of enzymes related to de novo ceramide biosynthesis. The accumulation of local inflammation and ceramide, a toxic lipid intermediate, can impair muscle growth. Metformin treatment may attenuate muscle loss by blunting inflammatory pathways and ceramide accumulation. Though metformin has traditionally served as an insulin sensitizer, its use as a preventive strategy to maintain muscle health during a period of physical inactivity in older adults has not been investigated. Therefore, we have proposed to conduct a clinical study in older adults to test whether metformin treatment during bed rest will attenuate muscle atrophy, weakness and muscle inflammatory mechanisms. These findings will be foundational in the development of novel treatments, such as metformin, to prevent muscle dysfunction in older adults during disuse periods.!

摘要老年人因疾病、受伤和/或手术而住院可能会损害身体活动能力，因此，老年人在住院期间和住院后都有能力进行体育活动。由此产生的久坐的生活方式可能会被接受为新的常态，最终增加骨骼肌的风险功能障碍(如骨质疏松症)。肌肉萎缩和力量丧失是老年人不使用运动的不幸后果。我们有通过我们对健康老年人的卧床休息研究观察到，除了肌肉和力量的变化外，骨骼肌炎症显著增加，与De相关的酶上调。新神经酰胺生物合成。局部炎症和神经酰胺的积累，神经酰胺是一种有毒的脂质中间体，会损害肌肉的生长。二甲双胍治疗可能通过钝化炎症途径来减轻肌肉损失和神经酰胺的积累。虽然二甲双胍传统上是胰岛素增敏剂，但它的用途是在老年人缺乏运动期间保持肌肉健康的预防性策略尚未得到调查过了。因此，我们建议在老年人中进行一项临床研究，以测试二甲双胍治疗卧床休息会减轻肌肉萎缩、虚弱和肌肉发炎的机制。这些这些发现将为开发新的治疗方法奠定基础，例如二甲双胍，以防止肌肉老年人在停用期间的功能障碍。